- Home
- TZOO vs IMA Comparison
TZOO vs IMA Comparison
Compare TZOO & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TZOO | IMA |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 65.3M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | TZOO | IMA |
|---|---|---|
| Price | $6.35 | $6.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $16.00 | $16.00 |
| AVG Volume (30 Days) | ★ 211.8K | 27.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.93 | N/A |
| Revenue Next Year | $9.25 | N/A |
| P/E Ratio | $17.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $5.70 |
| 52 Week High | $16.56 | $17.50 |
Technical Indicators
Market Signals| Indicator | TZOO | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 38.35 |
| Support Level | $4.72 | $5.97 |
| Resistance Level | $7.45 | $7.17 |
| Average True Range (ATR) | 0.44 | 0.34 |
| MACD | 0.10 | -0.08 |
| Stochastic Oscillator | 61.36 | 13.45 |
Price Performance
Historical ComparisonAbout TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.